Literature DB >> 33903956

Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis.

Tomaž Omerzu1, Jožef Magdič2, Radovan Hojs3,4, Uroš Potočnik3, Mario Gorenjak3, Tanja Hojs Fabjan2,3.   

Abstract

BACKGROUND: Multiple sclerosis is an inflammatory disorder of the central nervous system. Inflammation may create high susceptibility to subclinical atherosclerosis. The purpose of this study was to compare subclinical atherosclerosis and the role of inflammatory cytokines between the group of patients with relapsing-remitting multiple sclerosis (RRMS) and healthy controls matched for age and sex.
METHODS: The study group consisted of 112 non-diabetic and non-hypertensive RRMS patients treated with disease modifying drugs (DMD) and the control group was composed of 51 healthy subjects. The common carotid artery (CCA) intima media thickness (IMT) was investigated. Serum levels of risk factors for atherosclerosis and inflammatory cytokines were also determined.
RESULTS: The mean CCA IMT (0.572 ± 0.131 mm vs. 0.571 ± 0.114 mm) did not differ (p > 0.05) between patients and controls. The RRMS patients' CCA IMT was significantly correlated with serum interleukin 6 (IL-6) (p = 0.027), high-sensitivity C-reactive protein (hs-CRP) (p = 0.027), cystatin C (p < 0.0005), glucose (p = 0.031), cholesterol (p = 0.008), LDL (p = 0.021), erythrocyte sedimentation rate (p = 0.001) and triglyceride (p = 0.018) level. We fitted generalized linear models in order to assess the relationship between CCA IMT and IL‑6 with adjustment for sex and age. The obtained results showed that adjusted for age (p < 0.001) and sex (p = 0.048) IL‑6 serum levels statistically significantly (p = 0.009) predict CCA IMT only in the RRMS group.
CONCLUSION: The findings of the present study suggest that when treated with DMD RRMS might not be an independent risk factor for early atherosclerosis presenting with arterial wall thickening; however, the results suggest a significant association of IL‑6 serum levels with CCA IMT only in the RRMS group.

Entities:  

Keywords:  Carotid intima media thickness; Cystatin C; Inflammation; Interleukin 6; Neuroimmunology

Year:  2021        PMID: 33903956     DOI: 10.1007/s00508-021-01862-7

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  32 in total

1.  The changing face of multiple sclerosis: Prevalence and incidence in an aging population.

Authors:  C Solaro; M Ponzio; E Moran; P Tanganelli; R Pizio; G Ribizzi; S Venturi; G L Mancardi; M A Battaglia
Journal:  Mult Scler       Date:  2015-01-12       Impact factor: 6.312

Review 2.  Risk of vascular disease in patients with multiple sclerosis: a review.

Authors:  Christian Fynbo Christiansen
Journal:  Neurol Res       Date:  2012-06-16       Impact factor: 2.448

3.  Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study.

Authors:  H Roshanisefat; S Bahmanyar; J Hillert; T Olsson; S Montgomery
Journal:  Eur J Neurol       Date:  2014-07-17       Impact factor: 6.089

4.  Vascular dysfunction and physical activity in multiple sclerosis.

Authors:  Sushant M Ranadive; Huimin Yan; Madeline Weikert; Abbi D Lane; Mellissa A Linden; Tracy Baynard; Robert W Motl; Bo Fernhall
Journal:  Med Sci Sports Exerc       Date:  2012-02       Impact factor: 5.411

Review 5.  Comorbidity in multiple sclerosis: implications for patient care.

Authors:  Ruth Ann Marrie
Journal:  Nat Rev Neurol       Date:  2017-03-17       Impact factor: 42.937

6.  Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.

Authors:  Anja Thormann; Melinda Magyari; Nils Koch-Henriksen; Bjarne Laursen; Per Soelberg Sørensen
Journal:  J Neurol       Date:  2016-10-03       Impact factor: 4.849

7.  Pathogenesis of atherosclerosis: A multifactorial process.

Authors:  Raja B Singh; Sushma A Mengi; Yan-Jun Xu; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2002

Review 8.  Disease modifying therapies for relapsing multiple sclerosis.

Authors:  Dean M Wingerchuk; Brian G Weinshenker
Journal:  BMJ       Date:  2016-08-22

9.  Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.

Authors:  Hanne Marie Bøe Lunde; Jörg Assmus; Kjell-Morten Myhr; Lars Bø; Nina Grytten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-04-01       Impact factor: 10.154

10.  Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study.

Authors:  Ali Manouchehrinia; Christopher R Tench; Jonathan Maxted; Rashid H Bibani; John Britton; Cris S Constantinescu
Journal:  Brain       Date:  2013-06-11       Impact factor: 13.501

View more
  1 in total

1.  Carotid intima-media thickness measurements in patients with multiple sclerosis.

Authors:  Marjan Rahimi Farzan; Sara Esmaeili; Zahra Mirzaasgari; Negin Mahmoudi Hamidabad; Seyedeh Niloufar Rafiei Alavi; Mohammad Taghi Joghataei; Mohammad Reza Motamed
Journal:  Ann Med Surg (Lond)       Date:  2022-02-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.